Review Article
The Essential Role of FoxO1 in the Regulation of Macrophage Function
Table 1
Implications of FoxO1 in macrophage functional regulation under disease settings.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: AS1842856, a pharmacologic inhibition of FoxO1; Ang, angiotensin; AA, arachidonic acid; ATRA, all-trans retinoic acid; RARα, retinoic acid receptor α; ICG-001,a known inhibitor of β-catenin/TCF transcription by selectively blocking the β-catenin/CREB-binding protein interaction; MMT, macrophage–myofibroblast transition; Nrf2, nuclear factor erythroid 2-related factor 2; CypD, cyclophilin D; PTEN, phosphatase and tensin homologue; LKB1, liver kinase B1; ADAR1, adenosine deaminase acting on double-stranded RNA 1. |